AstraZeneca: Accelerating Drug Discovery with Machine Learning and AI on Cambridge-1

15 193
16.7
NVIDIA1.47 млн
Опубликовано 7 сентября 2021, 20:35
AstraZeneca is powering modern #machinelearning (ML) and AI to accelerate drug discovery with Cambridge-1, training models to learn the grammar of chemistry, and processing whole slide digital pathology images.

Learn more about #healthcare and life sciences research on NVIDIA Cambridge-1: nvda.ws/3yPKmf1
автотехномузыкадетское